Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Obese Children

被引:20
|
作者
Hecht, Lior [1 ,2 ]
Weiss, Ram [1 ,2 ,3 ]
机构
[1] Hadassah Hebrew Univ Sch Med, Dept Human Metab & Nutr, IL-91120 Jerusalem, Israel
[2] Hadassah Hebrew Univ Sch Med, Sect Pediat Endocrinol, IL-91120 Jerusalem, Israel
[3] Hadassah Hebrew Univ Sch Med, Dept Human Metab & Nutr, Braun Sch Publ Hlth, IL-91120 Jerusalem, Israel
关键词
Nonalcoholic fatty liver disease (NAFLD); Insulin resistance; Insulin clearance; Type; 2; diabetes; INSULIN-RESISTANCE; METABOLIC SYNDROME; GLUCOSE-TOLERANCE; HEPATIC STEATOSIS; SKELETAL-MUSCLE; GUT MICROBIOTA; ADOLESCENTS; PREVALENCE; ADIPONECTIN; ASSOCIATION;
D O I
10.1007/s11892-013-0448-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is commonly found in adults and adolescents with type 2 diabetes (T2DM). The cause-effect relations of these 2 conditions are complex and it is difficult to decipher whether one drives the other or vice versa. Genetic predispositions, along with obesity, are probably shared culprits of both. NAFLD may precede the diagnosis of diabetes and play a critical role of driving its development by way of increasing hepatic and whole body insulin resistance. On the other hand, T2DM is associated with hyperinsulinemia, a resistance to some of the effects of gut derived peptides and increased systemic free fatty acids, that can all promote hepatic lipid deposition. Thus, each condition may promote the development of the other and their mutual presence creates a vicious cycle. Upon studying this complex interplay from another angle, reduction of liver fat significantly improves glucose metabolism in patients with T2DM highlighting the tight pathophysiological link between them.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Pharmacotherapy of type 2 diabetes in patients with chronic liver disease: focus on nonalcoholic fatty liver disease
    Raschi, Emanuel
    Mazzotti, Arianna
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    Marchesini, Giulio
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (17) : 1903 - 1914
  • [42] FOCUS ON THE TYPE 2 DIABETES PATIENT WITH LIVER DISEASE: EMPHASIS ON NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Cusi, Kenneth
    ENDOCRINE PRACTICE, 2011, 17 : 9 - 13
  • [43] Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease and type 2 diabetes
    Pennisi, G.
    Enea, M.
    Falco, V.
    Aithal, G. P.
    Palaniyappan, N.
    Yilmaz, Y.
    Boursier, J.
    Cassinotto, C.
    De Ledinghen, V.
    Chan, W. K.
    Mahadeva, S.
    Eddowes, P.
    Newsome, P.
    Karlas, T.
    Wiegand, J.
    Wong, V. Wai-Sun
    Schattenberg, J. M.
    Labenz, C.
    Kim, W.
    Lee, M. S.
    Lupsor-Platon, M.
    Cobbold, J. F. L.
    Fan, J.
    Shen, F.
    Staufer, K.
    Trauner, M.
    Stauber, R.
    Nakajima, A.
    Yoneda, M.
    Bugianesi, E.
    Younes, R.
    Gaia, S.
    Zheng, M.
    Camma, C.
    Anstee, Q. M.
    Mozes, F. E.
    Pavlides, M.
    Petta, S.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S12 - S13
  • [44] Diabetes and Nonalcoholic Fatty Liver Disease
    Kantartzis, Konstantinos
    Gastaldelli, Amalia
    Magkos, Faidon
    Lavoie, Jean-Marc
    EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [45] Nonalcoholic fatty liver disease and diabetes
    Bellini, Maria Irene
    Urciuoli, Irene
    Del Gaudio, Giovanni
    Polti, Giorgia
    Iannetti, Giovanni
    Gangitano, Elena
    Lori, Eleonora
    Lubrano, Carla
    Cantisani, Vito
    Sorrenti, Salvatore
    D'Andrea, Vito
    WORLD JOURNAL OF DIABETES, 2022, 13 (09) : 668 - 682
  • [46] The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
    Dai, Chia-Yen
    Fang, Tzu-Jung
    Hung, Wei-Wen
    Tsai, Hui-Ju
    Tsai, Yi-Chun
    BIOMEDICINES, 2022, 10 (07)
  • [47] Impact of Diabetes Mellitus and Insulin on Nonalcoholic Fatty Liver Disease in the Morbidly Obese
    Strey, Claudia B. M.
    de Carli, Luiz A.
    Pioner, Sergio R.
    Fantinelli, Marciane
    Gobbato, Sabrina S.
    Bassols, Guilherme F.
    Losekann, Alexandre
    Coral, Gabriela P.
    ANNALS OF HEPATOLOGY, 2018, 17 (04) : 585 - 591
  • [48] The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes
    Younossi, Zobair M.
    Golabi, Pegah
    Price, Jillian Kallman
    Owrangi, Soroor
    Gundu-Rao, Nagashree
    Satchi, Romona
    Paik, James M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (10) : 1999 - 2010
  • [49] Importance of the liver ultrasound scores in pubertal obese children with nonalcoholic fatty liver disease
    Akcam, Mustafa
    Boyaci, Aslihan
    Pirgon, Ozgur
    Koroglu, Mert
    Dundar, Bumin N.
    CLINICAL IMAGING, 2013, 37 (03) : 504 - 508
  • [50] IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Bian, Hua
    Zhu, Xiaopeng
    Xia, Mingfeng
    Yan, Hongmei
    Chang, Xinxia
    Hu, Xiqi
    Pan, Baishen
    Guo, Wei
    Li, Xiaoying
    Gao, Xin
    ENDOCRINE PRACTICE, 2020, 26 (04) : 444 - 453